Atlas Trials

Open-Label Psilocybin Study in Transdiagnostic Population

Clinical trial NCT06442423 · RECRUITING

Trial details

NCT number
NCT06442423
Sponsor
Yale University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
TransdiagnosticDepression - Major Depressive DisorderAnxietyPTSD SymptomsPTSDSubstance UseSubstance Use Disorder (SUD)OCD
Start date
2024-10-17
Primary completion
2027-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.